中文 | English
Return
Total: 263 , 1/27
Show Home Prev Next End page: GO
Author:(Hu-Jiang SHI)

1.Construction and application of the "Huaxi Hongyi" large medical model

Rui SHI ; Bing ZHENG ; Xun YAO ; Hao YANG ; Xuchen YANG ; Siyuan ZHANG ; Zhenwu WANG ; Dongfeng LIU ; Jing DONG ; Jiaxi XIE ; Hu MA ; Zhiyang HE ; Cheng JIANG ; Feng QIAO ; Fengming LUO ; Jin HUANG

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2025;32(05):587-593

2.Bone loss in patients with spinal cord injury: Incidence and influencing factors.

Min JIANG ; Jun-Wei ZHANG ; He-Hu TANG ; Yu-Fei MENG ; Zhen-Rong ZHANG ; Fang-Yong WANG ; Jin-Zhu BAI ; Shu-Jia LIU ; Zhen LYU ; Shi-Zheng CHEN ; Jie-Sheng LIU ; Jia-Xin FU

Chinese Journal of Traumatology 2025;28(6):477-484

3.Effectiveness of Xuanshen Yishen Decoction on Intensive Blood Pressure Control: Emulation of a Randomized Target Trial Using Real-World Data.

Xiao-Jie WANG ; Yuan-Long HU ; Jia-Ming HUAN ; Shi-Bing LIANG ; Lai-Yun XIN ; Feng JIANG ; Zhen HUA ; Zhen-Yuan WANG ; Ling-Hui KONG ; Qi-Biao WU ; Yun-Lun LI

Chinese journal of integrative medicine 2025;31(8):677-684

4.High-dose estrogen impairs demethylation of H3K27me3 by decreasing Kdm6b expression during ovarian hyperstimulation in mice.

Quanmin KANG ; Fang LE ; Xiayuan XU ; Lifang CHEN ; Shi ZHENG ; Lijun LOU ; Nan JIANG ; Ruimin ZHAO ; Yuanyuan ZHOU ; Juan SHEN ; Minhao HU ; Ning WANG ; Qiongxiao HUANG ; Fan JIN

Journal of Zhejiang University. Science. B 2025;26(3):269-285

5.Enhanced radiotheranostic targeting of integrin α5β1 with PEGylation-enabled peptide multidisplay platform (PEGibody): A strategy for prolonged tumor retention with fast blood clearance.

Siqi ZHANG ; Xiaohui MA ; Jiang WU ; Jieting SHEN ; Yuntao SHI ; Xingkai WANG ; Lin XIE ; Xiaona SUN ; Yuxuan WU ; Hao TIAN ; Xin GAO ; Xueyao CHEN ; Hongyi HUANG ; Lu CHEN ; Xuekai SONG ; Qichen HU ; Hailong ZHANG ; Feng WANG ; Zhao-Hui JIN ; Ming-Rong ZHANG ; Rui WANG ; Kuan HU

Acta Pharmaceutica Sinica B 2025;15(2):692-706

6.Recent advances, strategies, and future perspectives of peptide-based drugs in clinical applications.

Qimeng YANG ; Zhipeng HU ; Hongyu JIANG ; Jialing WANG ; Han HAN ; Wei SHI ; Hai QIAN

Chinese Journal of Natural Medicines (English Ed.) 2025;23(1):31-42

7.Comprehensive Analysis of Oncogenic, Prognostic, and Immunological Roles of FANCD2 in Hepatocellular Carcinoma: A Potential Predictor for Survival and Immunotherapy.

Meng Jiao XU ; Wen DENG ; Ting Ting JIANG ; Shi Yu WANG ; Ru Yu LIU ; Min CHANG ; Shu Ling WU ; Ge SHEN ; Xiao Xue CHEN ; Yuan Jiao GAO ; Hongxiao HAO ; Lei Ping HU ; Lu ZHANG ; Yao LU ; Wei YI ; Yao XIE ; Ming Hui LI

Biomedical and Environmental Sciences 2025;38(3):313-327

8.Analysis of Tongue and Face Image Features of Anemic Women and Construction of Risk-Screening Model.

Hong Yuan FU ; Yi CHUN ; Ya Han ZHANG ; Yu WANG ; Yu Lin SHI ; Tao JIANG ; Xiao Juan HU ; Li Ping TU ; Yong Zhi LI ; Jia Tuo XU

Biomedical and Environmental Sciences 2025;38(8):935-951

9.Bibliometric and Visual Analysis of the Application of in situ Simulation in Medical Field.

Peng-Xia SUN ; Di JIANG ; Shu-Ya LI ; Yan SHI ; Shao-Wen HU ; Jing CHEN ; Fan LI

Acta Academiae Medicinae Sinicae 2025;47(5):830-842

10.Study on the mechanism of Yigong Powder in the treatment of anemia of chronic disease by means of formula components analysis based on activating spleen method

Ling SHI ; Yuting JI ; Qin ZHENG ; Yiling JIANG ; Jie HU ; Ruifeng ZHANG ; Zhihao WU ; Li XIA ; Aiping ZHANG ; Haitao XU ; Meihong LUO

Journal of Beijing University of Traditional Chinese Medicine 2024;47(9):1247-1255

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 263 , 1/27 Show Home Prev Next End page: GO